Viewing Study NCT01164150

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:05 PM
Ignite Modification Date: 2026-02-01 @ 1:58 PM
Study NCT ID: NCT01164150
Status: TERMINATED
Last Update Posted: 2023-04-06
First Post: 2010-07-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Sponsor: Cancer Trials Ireland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometrial Cancer View
None Gastrointestinal Complications View
None Radiation Toxicity View
None Urinary Complications View
Keywords:

Keywords

Keyword Brief Keyword Text View
None gastrointestinal complications View
None urinary complications View
None radiation toxicity View
None recurrent endometrial carcinoma View
None endometrial adenocarcinoma View
None stage IA endometrial carcinoma View
None stage IB endometrial carcinoma View
None stage II endometrial carcinoma View
None stage IIIA endometrial carcinoma View
None stage IIIB endometrial carcinoma View
None stage IIIC endometrial carcinoma View